Health Canada approves first RSV vaccine for adults age 60 and over
Health Canada has approved the first vaccine for respiratory syncytial virus for adults age 60 and over, but its use may be"limited" during this fall's respiratory virus season.
Dr. Samir Sinha, director of geriatrics at Mount Sinai and University Health Network hospitals in Toronto, welcomed the vaccine's approval, saying that the significant risk RSV poses for seniors has been"underappreciated." But in an email to The Canadian Press, the Public Health Agency of Canada said the RSV vaccine would likely be available for"limited use during the 2023/2024 fall/winter respiratory virus season."
"The Government of Canada will work with provinces and territories to determine potential demand and timelines should they decide to introduce Arexvy into their RSV vaccination programs." Federal, provincial and territorial governments should also provide the RSV vaccine for free, he said, as cost would be a barrier to many seniors.
A new antibody drug – nirsevimab, also known by the brand name Beyfortus – was approved by Health Canada in April. Nirsevimab only requires one injection to protect babies during the RSV season. It’s not yet known how widely it will be recommended for babies in Canada this fall.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Health Canada approves first RSV vaccine for seniorsHealth Canada has approved the first vaccine for respiratory syncytial virus (RSV) for adults age 60 and over, manufacturer GSK says.
Read more »
Health Canada approves first RSV vaccine for adults age 60 and overDoctors have been calling for an RSV vaccine for seniors because although the virus is common, older people are much more likely to become severely ill and require hospitalization
Read more »
Health Canada approves first RSV vaccine for adults age 60 and overOTTAWA - Health Canada has approved the first vaccine for respiratory syncytial virus (RSV) for adults age 60 and over.
Read more »
Health Canada approves first RSV vaccine for adults age 60 and overHealth Canada has approved the first vaccine for respiratory syncytial virus (RSV) for adults age 60 and over.
Read more »
Health Canada approves first RSV vaccine for adults age 60 and overHealth Canada has approved the first vaccine for respiratory syncytial virus (RSV) for adults age 60 and over.
Read more »
Health Canada approves first RSV vaccine for adults age 60 and over - Terrace StandardArexvy found to be 82 per cent effective at preventing lower respiratory tract disease caused by RSV
Read more »